Shistik Galina, Prakash Amy V, Fenske Neil A, Glass L Frank
Department of Dermatology and Cutaneous Surgery, University of South Florida, Tampa, FL 33612, USA.
J Drugs Dermatol. 2007 Aug;6(8):830-2.
We report a case of an 83-year-old female with locally metastatic melanoma treated with imiquimod and tazarotene. The patient originally presented to our dermatology clinic with local metastases of malignant melanoma after having undergone multiple surgical procedures and adjuvant radiation therapy for disease recurrence. At this juncture, she refused further surgical management but was interested in topical therapy. A 4-week course of topical imiquimod therapy was initiated. As no clinical response was noted at the end of the treatment period, tazarotene cream was introduced. The patient experienced complete clinical clearance of the treated area after a 6-week course of combination imiquimod and tazarotene therapy. The rationale for using both medications will be discussed.
我们报告一例83岁女性局部转移性黑色素瘤患者,接受了咪喹莫特和他扎罗汀治疗。该患者最初因疾病复发接受了多次外科手术和辅助放疗后,以恶性黑色素瘤局部转移的情况前来我们皮肤科诊所就诊。此时,她拒绝进一步的手术治疗,但对局部治疗感兴趣。于是开始了为期4周的外用咪喹莫特治疗。由于在治疗期结束时未观察到临床反应,遂引入他扎罗汀乳膏。在咪喹莫特和他扎罗汀联合治疗6周后,患者治疗区域实现了完全的临床清除。将讨论使用这两种药物的基本原理。